Charles Bonnet Syndrome

Charles Bonnet Syndrome ( CBS for short) is defined as visual hallucinations occurring in patients with severe vision loss who have a normal cognitive function.  This condition was first described in 1760 and affects about 30% of people with severe vision loss.

People experiencing CBS sees objects that they know are not real.  

Floaters – treatment options

Virtually all adults experience floaters to some degree.  Floaters may appear as dots,  lines, or a blurry haze in the field of vision that moves with eye movement. Floaters are more noticeable in bright settings such as a snow-covered ground or a bright sunny day.  For the most part, floaters are just a part of getting older.  

AREDS 2 Vitamins

RCSC has offered AREDS 2 vitamins at our office locations for a couple of reasons.  First, we want to make it convenient for our patient to attain the correct vitamins per the NEI recommendation. Second, we use all the proceeds from vitamins sales to donate to charity.   Our practice has consistently been one of the largest donors to the Foundation For Fighting Blindness and other charities in the state of Colorado.  

Flashes and Floaters

One of the most common symptoms that we hear about in our clinic are flashes and floaters.

Patients often describe floaters as a sudden onset of tiny dots, a new greyish glob, or a cloudlike film that floats back and forth in their field of vision.  Floaters are most noticeable bright settings and especially against a bright background.

Frequently Asked Questions (FAQ): Website Guidelines

I’m doctor James Luu.  I write most if not all of the articles on this website.  I write on topics that I feel are of interest to my patients and patients at RCSC.  I’d like set some usage guidelines.  I do my best to keep the information current and accurate.  The information in the articles is not meant to diagnose or treat any conditions.  

AREDS 2 Vitamins and AMD

Age-related macular degeneration (AMD) is the leading cause of blindness in the United States. Over 11 million people are affected and this number is expected to double by 2050. Most patients have dry AMD which can lead to gradual loss of central vision, usually over many years. About 10% of patients with dry AMD will develop swelling or bleeding in the macula.

START TYPING AND PRESS ENTER TO SEARCH